Therapy Impacts Long-Term Survival for Patients in Germany With Heritable Retinoblastoma
Journal of Clinical Oncology (JCO) Podcast · Rachel Brennan
July 5, 201610m 39s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
While ten-year overall survival has increased for German patients with heritable retinoblastoma, treatment modalities including radiation and/or chemotherapy can impact overall survival.